$TRTC Updated: 03-07-2017 TRTC Last Trade: Today

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
104
$TRTC Updated: 03-07-2017 TRTC
Last Trade: Today 15:59:58
Last 0.269   -0.001 (-0.40%)
Open 0.271
Previous Close 0.270
Day High / Low 0.288 / 0.266
Year High / Low 0.660 / 0.058
Volume 4,155,462
Projected Volume 4,155,462 (87%)
# of Trades / Projected 858 / 858
Dividend / Yield 0.00 / 0.00%
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle BEARISH
Volatility Today MEDIUM
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 80%
From 80 Day High 55%
From 150 Day High 51%
From 40 Day Low 106%
From 80 Day Low 106%
From 150 Day Low 106%
Pivot Analysis
Price Pivot $ 0.270
Day Resistance 1 $ 0.280
Day Support 1 $ 0.260
Day Resistance 2 $ 0.300
Day Support 2 $ 0.250
Consolidations
Short Term YES
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 4,750,568
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 6,553,949
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bearish
40 Day Trend bearish
100 Day Trend bearish
Stochastics bearish
RSI bearish
MACD bearish
Moving Average Indictors
15 Day Trend bearish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday HIGH
10 Day Volatility DECREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ipsen's Kayfanda® Receives EU Approval for Alagille Syndrome Treatment

Updated Category News Views 67

Kayfanda® Receives Approval for Treatment in the EU Ipsen has made a noteworthy advancement in pediatric healthcare with the recent authorization of Kayfanda® (odevixibat) in the European Union (EU). This innovative treatment specifically addresses cholestatic pruritus, a painful symptom linked to Alagille Syndrome, a rare liver disorder that affects children. This...

Continue Reading
Discover the Remarkable Returns of Vulcan Materials Stock

Updated Category News Views 144

Unveiling Vulcan Materials Company Stock Performance Vulcan Materials Co. (NYSE: VMC) has been a noteworthy performer in the stock market over the past 15 years, surpassing market expectations with a commendable annual return of 15.1%. This stock has consistently outperformed the market, achieving an admirable 2.86% advantage annually. With a current market capitalization...

Continue Reading
AeroPress Launches Premium Coffee Press with Elegant Design

Updated Category News Views 332

AeroPress introduced its Premium coffee press back in 2024, and you can bet the market was watching closely. With a retail price of $149.95, this isn’t just another brewing tool; it’s a statement piece designed for those who take their morning ritual seriously. Traders buzzed about how this could impact sales in a saturated market where every new gadget fights for...

Continue Reading
Investigation Update: Walgreens Boots Alliance Class Action Lawsuit

Updated Category News Views 327

Overview of the Walgreens Boots Alliance Class Action Levi & Korsinsky, LLP has raised awareness among investors regarding a class action securities lawsuit involving Walgreens Boots Alliance, Inc. This company, known for its extensive pharmaceutical and retail operations, is currently facing legal challenges that could significantly impact its investors. Class Definition...

Continue Reading
Savillex Strengthens Market Position with New Acquisition

Updated Category News Views 38

Savillex Acquires Optimum Processing to Enhance Offerings Thompson Street Capital Partners (TSCP) is proud to announce that its portfolio company, Savillex, has completed the acquisition of Optimum Processing, Inc. This strategic move is expected to elevate Savillex's position in the marketplace by combining its innovative fluid handling solutions with Optimum...

Continue Reading